Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Intensity Modulated Radiotherapy: Advantages, Limitations and Future Developments

Cheung, K.Y., (2006) Intensity Modulated Radiotherapy: Advantages, Limitations and Future Developments. Biomedical Imaging and Intervention Journal, 2 (1). e19, 19p..

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3108Kb

Official URL: http://www.biij.org/2006/1/e19/e19.pdf

Affiliations

Prince of Wales Hospital, Hong Kong, Dept. of Clinical Oncology

Abstract

Intensity modulated radiotherapy (IMRT) is widely used in clinical applications in developed countries, for the treatment of malignant and non-malignant diseases. This technique uses multiple radiation beams of non-uniform intensities. The beams are modulated to the required intensity maps for delivering highly conformal doses of radiation to the treatment targets, while sparing the adjacent normal tissue structures. This treatment technique has superior dosimetric advantages over 2 dimensional (2D) and conventional 3-dimensional conformal radiotherapy (3DCRT) treatments. It can potentially benefit the patient in three ways. First, by improving conformity with target dose it can reduce the probability of in-field recurrence. Second, by reducing irradiation of normal tissue it can minimise the degree of morbidity associated with treatment. Third, by facilitating escalation of dose it can improve local control. Early clinical results are promising, particularly in the treatment of nasopharyngeal carcinoma (NPC). However, as the IMRT is a sophisticated treatment involving high conformity and high precision, it has specific requirements. Therefore, tight tolerance levels for random and systematic errors, compared with conventional 2D and 3D treatments, must be applied in all treatment and pre-treatment procedures. For this reason, a large-scale routine clinical implementation of the treatment modality demands major resources and, in some cases, is impractical. This paper will provide an overview of the potential advantages of the IMRT, methods of treatment delivery, and equipment currently available for facilitating the treatment modality. It will also discuss the limitations of the equipment and the ongoing development work to improve the efficiency of the equipment and the treatment techniques and procedures.

Item Type:Journal
Keywords:IMRT, Dose Optimisation, IGRT, Motion Compensation
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:4382

1. Curran BH. Conformal therapy using a multileaf intensity modulating collimator. Sternick ES. The Theory & Practice of Intensity Modulated Radiation Therapy. Advanced Medical Publishing, 1997:75-90.

2. Bortfeld TR, Kahler DL, Waldron TJ, et al. X-ray field compensation with multileaf collimators. Int J Radiat Oncol Biol Phys 1994;28(3):723-30.

3. Spirou SV, Chui CS. Generation of arbitrary intensity profiles by dynamic jaws or multileaf collimators. Med Phys 1994;21(7):1031-41.

4. Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. Phys Med Biol 1995;40(9):1435-49.

5. Adler JR, Cox RS. Preliminary clinical experience with the Cyberknife: Image-guided Stereotactic radiosurgery. Radiosurgery 1995;1:316-26.

6. Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1993;20(6):1709-19.

7. Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47(3):551-60.

8. Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003;56(1):145-57.

9. Burman C, Chui CS, Kutcher G, et al. Planning, delivery, and quality assurance of intensity modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;39(4):863-73.

10. Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49(3):623-32.

11. Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46(1):195-205.

12. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity modulated radiotherapy for advancedstage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;58(4):1258-67.

13. Hong L, Alektiar K, Chui C, et al. IMRT of large fields: wholeabdomen irradiation. Int J Radiat Oncol Biol Phys 2002;54(1):278-89.

14. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54(5):1336-44.

15. Cho BC, Hurkmans CW, Damen EM, et al. Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol 2002;62(2):127-36.

16. van Asselen B, Raaijmakers CP, Hofman P, et al. An improved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother Oncol 2001;58(3):341-7.

17. Nutting CM, Rowbottom CG, Cosgrove VP, et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensitymodulated techniques. Radiother Oncol 2001;60(2):163-72.

18. Pirzkall A, Carol M, Lohr F, et al. Comparison of intensitymodulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys 2000;48(5):1371-80.

19. Teo P, Tsao SY, Shiu W, et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int J Radiat Oncol Biol Phys 1989;17(3):515-30.

20. Sham JS, Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and shortterm survival. Head Neck 1991;13(4):298-310.

21. Teo PM, Leung SF, Fowler J, et al. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals. Radiother Oncol 2000;57(2):155-66.

22. Teo PM, Leung SF, Lee WY, et al. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 2000;46(2):445-58.

23. Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003;56(4):1046-54.

24. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004;60(5):1440-50.

25. Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;64(2):374-81.

26. Ho JHC. Nasopharynx. Halnan KE. Treatment of Cancer. London: Chapman & Hall, 1982:249-68.

27. Chau RM, Teo PM, Choi PH, et al. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol 2001;58(2):143-53.

28. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53(1):12-22.

29. Wolden SL, et al. Advances in radiation therapy for nasopharyngeal carcinoma. Perry MC. Proceedings of the 38th Annual Meeting of American Society of Clinical Oncology. 565- 71.

30. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45(3):577-87.

31. Ashman JB, Zelefsky MJ, Hunt MS, et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensitymodulated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63(3):765-71.

32. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53(5):1111-6.

33. Teh BS, Mai WY, Uhl BM, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 2001;49(3):705-12.

34. De Meerleer G, Vakaet L, Meersschout S, et al. Intensitymodulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 2004;60(3):777-87.

35. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 2000;48(5):1559-68.

36. Beriwal S, Heron D, et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: A comparative dosimetry study with early clinical outcome. Int J Radiat Oncol Biol Phys 2005;63:S218.

37. Ben-Josef E, Shields AF, Vaishampayan U, et al. Intensitymodulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;59(2):454-9.

38. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006;64(2):363-73.

39. Milano MT, Jani AB, Farrey KJ, et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005;63(2):354-61.

40. Cheung KY, Ngar YK, et al. Intensity modulated stereotactic radiotherapy in treatment of head and neck tumours. Proceedings of the World Congress in Medical Physics and Biomedical Engineering.

41. Yin FF, Ryu S, Ajlouni M, et al. A technique of intensitymodulated radiosurgery (IMRS) for spinal tumors. Med Phys 2002;29(12):2815-22.

42. Brahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol 1988;12(2):129-40.

43. Webb S. Optimisation of conformal radiotherapy dose distributions by simulated annealing. Phys Med Biol 1989;34(10):1349-70.

44. Webb S. Optimization by simulated annealing of threedimensional conformal treatment planning for radiation fields defined by a multileaf collimator. Phys Med Biol 1991;36(9):1201-26.

45. Webb S. Optimization of conformal radiotherapy dose distributions by simulated annealing: 2. Inclusion of scatter in the 2D technique. Phys Med Biol 1991;36(9):1227-37.

46. Webb S. Optimization by simulated annealing of threedimensional, conformal treatment planning for radiation fields defined by a multileaf collimator: II. Inclusion of two-dimensional modulation of the x-ray intensity. Phys Med Biol 1992;37(8):1689-704.

47. Mohan R, Mageras GS, Baldwin B, et al. Clinically relevant optimization of 3-D conformal treatments. Med Phys 1992;19(4):933-44.

48. Bortfeld T, Burkelbach J, Boesecke R, et al. Methods of image reconstruction from projections applied to conformation radiotherapy. Phys Med Biol 1990;35(10):1423-34.

49. Coia LR, Schultheiss TE, et al. A practical Guide to CT simulation. Advanced Medical Publishing, 1995.

50. Mah D, Steckner M, Hanlon A, et al. MRI simulation: effect of gradient distortions on three dimensional prostate cancer plans. Int J Radiat Oncol Biol Phys 2002;53(3):757-65.

51. De Ruysscher D, Wanders S, Minken A, et al. Effects of radiotherapy planning with a dedicated combined PET-CTsimulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 2005;77(1):5-10.

52. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51(4):880-914.

53. Galvin JM, Ezzell G, Eisbrauch A, et al. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004;58(5):1616-34.

54. Lee KY, Chau MC, et al. Design of an in-expensive phantom for IMRT verification. Radiother Oncol 2001;61:S110.

55. Tsai JS, Wazer DE, Ling MN, et al. Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients. Int J Radiat Oncol Biol Phys 1998;40(5):1213-30.

56. Wang X, Spirou S, LoSasso T, et al. Dosimetric verification of intensity-modulated fields. Med Phys 1996;23(3):317-27.

57. Low DA, Mutic S, Dempsey JF, et al. Quantitative dosimetric verification of an IMRT planning and delivery system. Radiother Oncol 1998;49(3):305-16.

58. Xing L, Chen Y, Luxton G, et al. Monitor unit calculation for an intensity modulated photon field by a simple scatter-summation algorithm. Phys Med Biol 2000;45(3):N1-7.

59. Lee KY, Chau MC, et al. Virtual pre-treatment verification for IMRT Treatments. Radiother Oncol 2001;61:S25.

60. Ploeger LS, Smitsmans MH, Gilhuijs KG, et al. A method for geometrical verification of dynamic intensity modulated radiotherapy using a scanning electronic portal imaging device. Med Phys 2002;29(6):1071-9.

61. Boellaard R, van Herk M, Uiterwaal H, et al. Two-dimensional exit dosimetry using a liquid-filled electronic portal imaging device and a convolution model. Radiother Oncol 1997;44(2):149-57.

62. Heijmen BJ, Pasma KL, Kroonwijk M, et al. Portal dose measurement in radiotherapy using an electronic portal imaging device (EPID). Phys Med Biol 1995;40(11):1943-55.

63. Van Esch A, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields. Radiother Oncol 2004;71(2):223-34.

64. Warkentin B, Steciw S, Rathee S, et al. Dosimetric IMRT verification with a flat-panel EPID. Med Phys 2003;30(12):3143-55.

65. LoSasso T, Chui CS, Ling CC. Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys 1998;25(10):1919-27.

66. Ling CC, Yorke E, Amols H, et al. High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated. Int J Radiat Oncol Biol Phys 2004;60(1):3-7.

67. van Herk M, Kooy HM. Automatic three-dimensional correlation of CT-CT, CT-MRI, and CT SPECT using chamfer matching. Med Phys 1994;21(7):1163-78.

68. Kessler ML, Pitluck S, Petti P, et al. Integration of multimodality imaging data for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 1991;21(6):1653-67.

69. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003;57(2):481-8.

70. Hamilton RJ, Sweeney PJ, Pelizzari CA, et al. Functional imaging in treatment planning of brain lesions. Int J Radiat Oncol Biol Phys 1997;37(1):181-8.

71. Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002;12(3):229-37.

72. Kiffer JD, Berlangieri SU, Scott AM, et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998;19(3):167-77.

73. Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42(5 Suppl):1S-93S.

74. Hany TF, Steinert HC, Goerres GW, et al. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002;225(2):575-81.

75. Lavrenkov K, Partridge M, Cook G, et al. Positron emission tomography for target volume definition in the treatment of nonsmall cell lung cancer. Radiother Oncol 2005;77(1):1-4.

76. Happersett L, Mageras GS, Zelefsky MJ, et al. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. Radiother Oncol 2003;66(3):263-70.

77. Mohan R, Zhang X, Wang H, et al. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 2005;61(4):1258-66.

78. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001;50(1):265-78.

79. Yan D, Lockman D, Brabbins D, et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48(1):289-302.

80. Mohan DS, Kupelian PA, Willoughby TR. Short-course intensitymodulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int J Radiat Oncol Biol Phys 2000;46(3):575-80.

81. Yan D, Vicini F, Wong J, et al. Adaptive radiation therapy. Phys Med Biol 1997;42(1):123-32.

82. Martinez AA, Yan D, Lockman D, et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001;50(5):1226-34.

83. Barker JL Jr, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004;59(4):960-70.

84. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 1999;44(4):911-9.

85. Ekberg L, Holmberg O, Wittgren L, et al. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol 1998;48(1):71-7.

86. Blomgren H, Lax I, et al. Radiosurgery for tumors in the body: Clinical method using a new method. Journal of Radiosurgery 1:63-5.

87. Wong J, Sharpe M, et al. The use of active breathing control (ABC) to minimize breathing motion in conformal therapy. Leavitt DD, Strkschall. Proc. 12th Int. Conf. on the Use of Computers in Radiation Therapy. 220-2.

88. Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53(3):199-203.

89. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56(1):83-8.

90. Teo PM, Ma BB, Chan AT. Radiotherapy for nasopharyngeal carcinoma--transition from two dimensional to three-dimensional methods. Radiother Oncol 2004;73(2):163-72.

91. Mutic S, Low DA, Klein EE, et al. Room shielding for intensity modulated radiation therapy treatment facilities. Int J Radiat Oncol Biol Phys 2001;50(1):239-46.

92. Cox JD, Azarnia N, Byhardt RW, et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8(9):1543-55.

93. Martel MK, Strawderman M, Hazuka MB, et al. Volume and dose parameters for survival of non small cell lung cancer patients. Radiother Oncol 1997;44(1):23-9.

94. Martel MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999;24(1):31-7.

95. Kam KM, et al. Pattern of local failure after primary 2-dimensional radiotherapy (2DRT) in non metastatic nasopharyngeal carcinoma patients: Predominance of within-field failure and hits on dose escalation effect. Proc. 11th Annual Scientific Symposium of the Hong Kong Cancer Institute. 57.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.